Paeds Cases · paediatric-dermatology
Explaining chronic plaque psoriasis and topical therapy — OSCE
Communication and structured-discussion OSCE on explaining a new diagnosis of chronic plaque psoriasis in an 11-year-old to a parent, covering the nature of the chronic immune-mediated disease, the potency-matched topical corticosteroid plus calcipotriol treatment and the face and flexure caution, the comorbidity screen for obesity, juvenile psoriatic arthritis and psychosocial burden, and the long-term partnership and escalation pathway to phototherapy and systemic therapy.
On this page
Study tools
Target exams
Candidate instructions (8-minute station)
You are the paediatric registrar in the clinic. An 11-year-old girl has a one-year history of thick, well-demarcated, scaly patches on the elbows, knees and scalp, with nail pitting. Her father has psoriasis, she is overweight, and she has become reluctant to wear short sleeves at school. The family asks whether the condition is contagious, whether the creams are safe, and whether it will go away. [1]
Your tasks are: [1]
- Explain the diagnosis of psoriasis in plain, reassuring language, including that it is not contagious and that it is a chronic immune-mediated condition that often runs in families. [2]
- Explain the topical treatment — a potency-matched corticosteroid plus calcipotriol — and the safety rules, including why a milder cream is used on the face and flexures. [1]
- Explain the comorbidities to watch for — weight, joints and mood — and why controlling the weight matters. [11]
- Set the expectation for the long term, including when stronger treatments such as phototherapy or a biologic might be considered. [1]
You are not expected to start a systemic or biologic agent in this station — that decision is made with a dermatologist. [9]
References4ShowHide
- [1]Menter A; Cordoro KM; Davis DMR; Feldman SR; et al Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. J Am Acad Dermatol, 2020.PMID 31703821
- [2]Eichenfield LF; Paller AS; Tom WL; Lara-Corrales I; et al Pediatric psoriasis: Evolving perspectives. Pediatr Dermatol, 2018.PMID 29314219
- [9]Paller AS; Siegfried EC; Langley RG; Gottlieb AB; et al Etanercept treatment for children and adolescents with plaque psoriasis. N Engl J Med, 2008.PMID 18199863
- [11]Phan K; Lee G; Fischer G Pediatric psoriasis and association with cardiovascular and metabolic comorbidities: Systematic review and meta-analysis. Pediatr Dermatol, 2020.PMID 32436322